bdcA

Overview

Drug Classes: Nalidixic acid|Norfloxacin|Ciprofloxacin|Levofloxacin, Norfloxacin
Organisms: E. coli, Escherichia coli
Papers: 2
Mutations: 1

Mutations

Protein Change	Nucleotide Change	Mechanism	Organism	Resistance To	Database	Validation Status
G135S	-	-	E. coli, Escherichia coli	Nalidixic acid\|Norfloxacin\|Ciprofloxacin\|LevofloxacinNorfloxacin	Reslit	Candidate

Papers2

Mutations in bdcA and valS Correlate with Quinolone Resistance in Wastewater Escherichia coli.

novel nonsynonymous mutation

Protein Change: G135S
Organisms: E. coli
Confers Resistance To: Nalidixic acid|Norfloxacin|Ciprofloxacin|Levofloxacin
Source Database: Reslit

Word-based GWAS harnesses the rich potential of genomic data for E. coli quinolone resistance.